Print

2016 Royal Society GSK Lecture

Written by Amar Puttanna on 15 August 2016. Modified on 16 August 2016. Hits: 1334

AddThis Social Bookmark Button

A free to attend lecture from the Royal Society being delivered by Professor Andrew Hattersley where he discusses the use of genetics to improve treatment of diabetes. 

When: 18:30-19:30 8th September 2016

Where: Royal Society, London

Click here for details

 

Professor Andrew Hattersley FRS will show how, for patients with pure genetic diabetes, defining the specific causes of a patient’s diabetes has resulted in dramatic improvements in their treatment. These findings have changed the management of patients born with diabetes or with strongly familial diabetes throughout the world and have led to molecular genetic testing becoming a first line clinical investigation. The fundamental principle of this Precision Medicine approach is that defining discrete aetiological subgroups of patients within a broader clinical diagnosis can improve clinical care for patients.

Professor Andrew Hattersley FMedSci FRS was awarded the 2016 Royal Society GlaxoSmithKline Prize and Lecture for his work on genetic and physiological studies of patients with common subtypes of monogenic diabetes revolutionising treatment for these patients.

The award was initially established following a donation from The Wellcome Foundation. Since 2002 it has been supported by GlaxoSmithKline Limited. The first award was made in 1980.

The Royal Society GlaxoSmithKline Prize and Lecture is awarded biennially for 'original contributions to medical and veterinary sciences published within ten years from the date of the award'. 

Our latest tweets